Albemarle (ALB) ended the recent trading session at $126.05, demonstrating a -1.85% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 0.42%. Meanwhile, the Dow gained 0.29%, and the Nasdaq, a tech-heavy index, added 0.29%.
The stock of specialty chemicals company has fallen by 19.26% in the past month, lagging the Basic Materials sector's loss of 4.07% and the S&P 500's gain of 2.2%.
The investment community will be paying close attention to the earnings performance of Albemarle in its upcoming release. The company is slated to reveal its earnings on August 5, 2026. The company is expected to report EPS of $3.21, up 2818.18% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $1.53 billion, up 15.08% from the year-ago period.
ALB's full-year Zacks Consensus Estimates are calling for earnings of $13.15 per share and revenue of $6.13 billion. These results would represent year-over-year changes of +1764.56% and +19.15%, respectively.
Investors might also notice recent changes to analyst estimates for Albemarle. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 6.14% higher. Albemarle is currently a Zacks Rank #1 (Strong Buy).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 9.77. This valuation marks a discount compared to its industry average Forward P/E of 14.96.
The Chemical - Diversified industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 109, putting it in the top 45% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Albemarle Corporation (ALB): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).